BRPI0417950A - composições farmacêuticas - Google Patents

composições farmacêuticas

Info

Publication number
BRPI0417950A
BRPI0417950A BRPI0417950-1A BRPI0417950A BRPI0417950A BR PI0417950 A BRPI0417950 A BR PI0417950A BR PI0417950 A BRPI0417950 A BR PI0417950A BR PI0417950 A BRPI0417950 A BR PI0417950A
Authority
BR
Brazil
Prior art keywords
pharmaceutical compositions
antagonists
relates
present
pharmaceutical
Prior art date
Application number
BRPI0417950-1A
Other languages
English (en)
Inventor
Mengwei Hu
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of BRPI0417950A publication Critical patent/BRPI0417950A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4747—Quinolines; Isoquinolines spiro-condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"COMPOSIçõES FARMACêUTICAS". A presente invenção refere-se a composições farmacêuticas compreendendo antagonistas de NK~ 1~.
BRPI0417950-1A 2003-12-22 2004-12-20 composições farmacêuticas BRPI0417950A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US53173503P 2003-12-22 2003-12-22
US2004072893 2004-12-20

Publications (1)

Publication Number Publication Date
BRPI0417950A true BRPI0417950A (pt) 2007-04-17

Family

ID=34738689

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0417950-1A BRPI0417950A (pt) 2003-12-22 2004-12-20 composições farmacêuticas

Country Status (16)

Country Link
US (1) US20050153999A1 (pt)
EP (1) EP1706116A1 (pt)
JP (1) JP2007515425A (pt)
KR (1) KR20060113737A (pt)
CN (1) CN1897942A (pt)
AR (1) AR046769A1 (pt)
AU (1) AU2004308935A1 (pt)
BR (1) BRPI0417950A (pt)
CA (1) CA2550432A1 (pt)
MX (1) MXPA06007210A (pt)
NO (1) NO20063393L (pt)
PE (1) PE20051049A1 (pt)
PL (1) PL380482A1 (pt)
TW (1) TW200531686A (pt)
WO (1) WO2005063243A1 (pt)
ZA (1) ZA200605080B (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR060352A1 (es) * 2006-04-05 2008-06-11 Schering Corp Sales de 8- [(1- (3,5-bis- (trifluorometil) fenil) -etoxi) -metil] -8-fenil-1,7 -diaza- espiro [4.5] decan -2-ona y proceso de preparacion de las mismas
ES2553805T3 (es) 2006-04-05 2015-12-11 Opko Health, Inc. Formulaciones farmacéuticas que comprenden sales de (5S,8S)-8-[{(1R)-1-(3,5-bis-(trifluorometil)fenil]-etoxi}-metil]-8-fenil-1,7-diazaespiro[4.5]decan-2-ona y su utilización médica
PE20071220A1 (es) * 2006-04-05 2007-12-14 Opko Health Inc Sales de hidrocloruro de 8-[{1-(3,5-bis-(trifluorometil)fenil)-etoxi}-metil]-8-fenil-1,7-diaza-espiro[4.5]decan-2-ona y su proceso de preparacion
PE20081891A1 (es) * 2007-03-22 2008-12-27 Opko Health Inc Formulaciones de comprimidos que contienen sales de 8-[{1-(3,5-bis-(trifluorometil)fenil)-etoxi}-metil]-8-fenil-1,7-diaza-spiro[4.5]decan-2-ona y comprimidos elaborados a partir de estas
AR066191A1 (es) * 2007-03-22 2009-08-05 Schering Corp Proceso e intermediarios para la sintesis de compuestos 8- [ ( 1- (3,5- bis- ( trifluorometil) fenil) - etoxi ) - metil]- 8 fenil - 1,7- diaza - espiro (4, 5) decan -2 ona
PE20110777A1 (es) * 2008-11-23 2011-10-29 Pfizer Nuevas lactamas como inhibidores de beta secretasa
JP5860399B2 (ja) * 2009-08-14 2016-02-16 オプコ ヘルス， インコーポレイテッド ニューロキニン−１アンタゴニストの静脈内用製剤
AU2014271269B2 (en) * 2009-08-14 2016-11-03 Opko Health, Inc. Intravenous formulations of neurokinin-1 antagonists
IL298436B1 (en) * 2012-01-23 2024-03-01 Sage Therapeutics Inc Pharmaceutical preparations that include allopregnanolone
NL2018041B1 (en) * 2016-12-22 2018-06-28 Land Life Company B V Process to prepare a biodegradable pulp product
CN114126596A (zh) * 2019-05-15 2022-03-01 贝克森生物医药公司 用于皮下注射的氯胺酮制剂
BR112021026554A2 (pt) * 2019-06-28 2022-05-24 Jiangsu Hengrui Medicine Co Antagonista de neurocinina-1
IL296635A (en) 2020-04-03 2022-11-01 Nerre Therapeutics Ltd An nk-1 receptor antagonist for the treatment of a disease selected from sepsis, septic shock, acute respiratory distress syndrome (ARDS), or multiple organ dysfunction syndrome (MODS)
IL298589A (en) 2020-06-02 2023-01-01 Nerre Therapeutics Ltd Neurokinin (nk)-1 receptor antagonists for use in the treatment of pulmonary fibrosis promoted by mechanical lung injury
JP2024501994A (ja) * 2020-12-25 2024-01-17 上海盛迪医▲葯▼有限公司 Ｎｋ１拮抗剤プロドラッグ化合物と５－ｈｔ３受容体拮抗剤との併用使用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2791346B3 (fr) * 1999-03-25 2001-04-27 Sanofi Sa Nouveaux derives de morpholine, procede pour leur preparation et compositions pharmaceutiques les contenant
WO2002074200A1 (en) * 2001-03-20 2002-09-26 Cydex, Inc. Formulations containing propofol and a sulfoalkyl ether cyclodextrin
PE20030762A1 (es) * 2001-12-18 2003-09-05 Schering Corp Compuestos heterociclicos como antagonistas nk1

Also Published As

Publication number Publication date
ZA200605080B (en) 2008-06-25
AR046769A1 (es) 2005-12-21
TW200531686A (en) 2005-10-01
WO2005063243A1 (en) 2005-07-14
MXPA06007210A (es) 2006-08-18
JP2007515425A (ja) 2007-06-14
KR20060113737A (ko) 2006-11-02
PL380482A1 (pl) 2007-02-05
NO20063393L (no) 2006-07-21
CA2550432A1 (en) 2005-07-14
CN1897942A (zh) 2007-01-17
US20050153999A1 (en) 2005-07-14
AU2004308935A1 (en) 2005-07-14
PE20051049A1 (es) 2006-01-03
EP1706116A1 (en) 2006-10-04

Similar Documents

Publication Publication Date Title
GB2389530B (en) Pharmaceutical compositions
HRP20080564T3 (en) Dihydrotetrabenazines and pharmaceutical compositions containing them
NO20052306D0 (no) Dispergerbare farmasoytiske blandinger.
GB0320382D0 (en) Pharmaceutical compositions
GB0327723D0 (en) Pharmaceutical compositions
DE60311307D1 (de) Shampoo-zusammensetzungen
BRPI0417950A (pt) composições farmacêuticas
GB0218004D0 (en) Pharmaceutical compositions
MX2007006241A (es) 2-alcoxi-3,4,5-trihidroxi-alquilamidas, su preparacion, composiciones que las contienen y su utilizacion.
IS7051A (is) Lyfjasamsetningar
DE602004018512D1 (de) Stifte zusammensetzungen
GB0300531D0 (en) Pharmaceutical compositions
NO20063293L (no) Farmasoytiske forbindelser
DE60320902D1 (de) Zusammensetzungen mit ausgelöster Freisetzung
DE60316954D1 (de) Shampoozusammensetzungen
HU0302441D0 (en) Pharmaceutical compositions having antibiothic effect
BRPI0313645A2 (pt) composições de inalação com relações de droga elevadas.
BRPI0408446A (pt) tablete de limpeza
GB0213481D0 (en) Pharmaceutical compositions
BRPI0411820A (pt) composição farmacêutica
HU0304095D0 (en) Novel, effective pharmaceutical compositions
FR2887541B1 (fr) Compositions d'inertage d'impuretes
ITRE20040074A1 (it) "profumatore per ambienti"
BRPI0410638A (pt) derivados de azitromicina
GB0305579D0 (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]